XiFin Accelerates AI-Driven RCM Future with New Growth Funding and Addition of Visionary Leader Jeff Margolis to Its Board
- New investment to fuel growth trajectory and development of award-winning, next-gen XiFin® Empower platform
- Funding led by a co-investment from Goldman Sachs, alongside majority investor Avista Healthcare Partners and other leading institutional investors

XiFin welcomes Jeffrey H. Margolis, visionary Health IT innovator and board member for multiple companies, to its Board of Directors.
“XiFin is uniquely positioned to capitalize on an inflection point in the industry, with AI presenting a once-in-a-generation opportunity to modernize RCM,� said Erik Sallee, Chief Financial Officer at XiFin. “With the support of our blue-chip investors, we have excellent financial flexibility to continue solving complex healthcare challenges and delivering industry-leading technology to more partners.�
The new growth investments follow strong demand for XiFin’s award-winning technology infrastructure that unifies automation, data analytics, and AI to streamline revenue cycle workflows, improve financial performance, and enhance the patient/provider experience. Built with real-time data exchange and interoperability at its core, XiFin Empower RCM connects patients, healthcare and pharmaceutical providers, and payors across the health ecosystem, extending medical providers� reach for maximum operational and clinical impact.
“Our growth capital commitment underscores a strong conviction in XiFin and the critical role its industry-leading technology plays in modernizing healthcare RCM,� said Marc Boheim, Head of Co-Investments at Goldman Sachs External Investing Group. “We believe the company has an impressive trajectory of value creation, both organically and through acquisitions, as providers turn to trusted platforms like XiFin Empower RCM to help navigate the care delivery life cycle.�
Visionary Health IT Innovator Jeff Margolis Joins XiFin Board
XiFin’s Board will benefit from the addition of , a healthcare information technology veteran with extensive experience in AI innovation. He brings more than 35 years of expertise as an operating executive, having led as CEO multiple innovative healthcare technology companies, including founding TriZetto, the industry’s first vertical SaaS platform, with market-leading benefit plan administration solutions that serve over 130 million people. Margolis currently serves as a Senior Advisor to Blackstone, and board member for multiple companies, guiding strategic investments and advancing innovation in healthcare and IT. He is the author of several books evaluating the state of healthcare, including The Healthcare Cure and, most recently, Not Just in Sickness…but Also in Health.
“XiFin is supporting America’s healthcare providers—from hospitals and health systems, to pharmacies, ancillary and diagnostic services, to pharmaceutical companies—with solutions that unite a disconnected ecosystem, redefine RCM, and maintain focus on patient care,� Margolis said. “I am excited to work with XiFin’s management team and deep bench of industry experts to help providers capitalize on proprietary AI solutions that create tremendous efficiencies and benefit all stakeholders.�
About XiFin
XiFin is a healthcare information technology company that empowers organizations to navigate an evolving and increasingly complex healthcare landscape. Leveraging AI-enabled technologies and services, the XiFin Empower platform delivers enhanced operational efficiency, increased productivity and workflow automation. Our comprehensive set of solutions � spanning revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement � provides healthcare organizations with the tools they need to achieve financial strength, optimize operations, and implement industry-leading strategies. XiFin Empower solutions deliver THE POWER TO DO GOOD® so that healthcare organizations can do more good for more patients. Visit , follow XiFin on , or subscribe to the to learn more.
About Avista Healthcare Partners
Founded in 2005, Avista Healthcare Partners is a leading
About Goldman Sachs
Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over
View source version on businesswire.com:
Media Contact:
Peter Collins
(908) 499-1200
[email protected]
Source: XiFin